Alpha-1 Antitrypsin Deficiency Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of ALN-AAT02 in Healthy Participants and Participants With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease
Condition: ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease Interventions: Drug: ALN-AAT02; Drug: Placebo Sponsor: Alnylam Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2018 Category: Research Source Type: clinical trials
